Press releases
- Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
- U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
- Viatris Named to TIME's World's Most Sustainable Companies 2024 List
- Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024
- Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors
- Viatris to Participate in the Jeffries Global Healthcare Conference
- Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
- Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
- Viatris to Participate in the BofA Securities 2024 Health Care Conference
More ▼
Key statistics
As of last trade Viatris Inc (VIA:MUN) traded at 10.83, -12.72% below its 52-week high of 12.40, set on Feb 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.83 |
---|---|
High | 10.83 |
Low | 10.83 |
Bid | 10.62 |
Offer | 10.66 |
Previous close | 10.79 |
Average volume | 5.17k |
---|---|
Shares outstanding | 1.19bn |
Free float | 1.19bn |
P/E (TTM) | -- |
Market cap | 14.10bn USD |
EPS (TTM) | -0.0499 USD |
Annual div (ADY) | 0.4438 EUR |
---|---|
Annual div yield (ADY) | 4.11% |
Div ex-date | May 23 2024 |
Div pay-date | Jun 14 2024 |
Data delayed at least 15 minutes, as of Jul 22 2024 07:02 BST.
More ▼